CrossRef Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 20102023 Jialin Wu, Bonan Chen, Fuda Xie, Jiahui Hu, Mingyu Liang, Yang Lyu, Peiyao Yu, Tiejun Feng, Muyang Huang, Canbin Fang, Ka Fai To, Terry Cheuk-Fung Yip, Xingxin Wang, Wei Kang Hepatology International .2026;[Epub] CrossRef Development and Validation of a Deep Learningenabled Single Breath-hold Abbreviated MRI Protocol for Hepatocellular Carcinoma Diagnosis Yunfei Zhang, Zhijun Geng, Xianling Qian, Yuyao Xiao, Ruofan Sheng, Mengsu Zeng Radiology: Artificial Intelligence .2026;[Epub] CrossRef Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (20202025) Qi-Feng Chen, Song Chen, Xiongying Jiang, Jiongliang Wang, Ming Zhao Liver Cancer .2026
Interest in drugs like Ozempic and Wegovy for weight loss has grown rapidly over the past several years, with 6% of U.S
However, it remains important to consider that GLP-1 receptor agonists may be limited by unfavorable side effects, especially in the context of PD
Constipation prevention through diet Constipation affects roughly 10-15% of GLP-1 users and can become severe enough to require medical attention